Nuvectis Pharma, Inc. NVCT
21.08 USD +0.06 (+0.29%)
At closeNov 10, 2026, 4:01 PM EST
21.08 0.00 0.00%
After hours · Nov 10, 4:01 PM ET
20.23 Day range 21.30
5.77 52-week range 29.28
- YTD
- +179.21%
- 1 year
- +247.28%
Analyst view
Price target (mean) 22.00 +4.4% upside
Now 21.08
- Target (low)
- 20.00
- Target (mean)
- 22.00
- Target (high)
- 25.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 7, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jul 13, 2022 | Ladenburg Thalmann | Initiated | — | Buy |
| May 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 2, 2022 | HC Wainwright & Co. | Initiated | — | Buy |